Oramed Pharmaceuticals Inc.
ORMP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001176309
No open-market purchases or sales by Oramed Pharmaceuticals Inc. insiders were filed in the last 90 days; 84 institutions reported holding it in 13F filings for Q2 2026, worth $80.7M in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Oramed Pharmaceuticals Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 93 | 116 | +23 |
| Shares | 5.41M | 8.58M | +3.16M (+58.5%) |
| Value | $118.9M | $122.4M | +$3.57M (+3.0%) |
New holders (36)
Institutions that held Oramed Pharmaceuticals Inc. at the end of Q4 2021 but not at the end of Q3 2021.
Sold out (13)
Institutions that held Oramed Pharmaceuticals Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Jetstream Capital LLC | 120,000 | $2.64M |
| EAM Investors, LLC | 66,392 | $1.46M |
| Sabby Management, LLC | 40,344 | $887.0K |
| Man Group plc | 37,285 | $820.0K |
| Winton Group Ltd | 23,607 | $519.0K |
| Greylin Investment Mangement Inc | 18,900 | $415.0K |
| Belvedere Trading LLC | 11,972 | $269.0K |
| Dorsey Wright & Associates | 5,518 | $121.0K |
| FNY Investment Advisers, LLC | 2,195 | $48.0K |
| Kings Point Capital Management | 500 | $11.0K |
| Koshinski Asset Management, Inc. | 440 | $9.67K |
| Meeder Asset Management Inc | 95 | $3.00K |
| Eaton Vance Management | 65 | $0 |